Sri Lanka Approves US$702,000 Medicine Procurement Contract for Serious Infections

On 3 November, the Cabinet approved a US$702,000 contract for 54,000 vials of Liposomal Amphotericin B, used to treat serious infections including cryptococcal meningitis. India’s Gufic Biosciences received the contract, which includes cost and air-freight charges. The procurement creates opportunities for pharmaceutical suppliers and healthcare distributors. HPC can support medical procurement research, supplier assessments and healthcare-market advisory.

If you are interested to enquire further, please fill in the form below with your details and one of our consultants will contact you shortly.